Delivery Order SPE2DB22D2211-SPE2DB24FRHSR

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $24K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $27,185.10. The contract is a firm fixed-price, non-set-aside delivery order with a performance period through June 18, 2025. AmerisourceBergen Drug Corporation holds a significant Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract has a ceiling value of $120,860.95 and a period of performance ending on June 25, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $11,868.44 and a period of performance through April 11, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML. The contract is a firm fixed-price delivery order with a ceiling value of $9,950.38 and a period of performance through June 24, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of COSENTYX SNRDY 300MG DOSE-2PENML pharmaceutical product. The contract has a ceiling value of $53,792.53 and an ultimate completion date of August 6, 2024. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a large pharmaceutical distributor, is the prime contractor for this award, which is part of their broader...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a ceiling value of $16,862.02 and a completion date of June 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COSENTYX SNRDY 300MG DOSE-2PENML. The contract has a ceiling value of $15,616.14 and runs through April 10, 2025. It is a Firm Fixed Price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of the pharmaceutical product COSENTYX SNRDY 300MG DOSE-2PENML. The contract has a firm fixed price of $1,599.23 and a period of performance through September 25, 2024. AmerisourceBergen, as a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical to provide...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a prescription medication. The contract has a ceiling value of $30,447.93 and is a firm fixed-price delivery order with an ultimate completion date of May 29, 2025. The contract is not set-aside and is open to full and open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, with a ceiling value of $8,843.70. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a prescription medication. The delivery order has a period of performance through May 8, 2025 and is a firm fixed-price contract. The contract is not set-aside for any particular business category. AmerisourceBergen Drug Corp holds a significant...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FRHSR
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract has a ceiling value of $23,944.83 and will run through September 18, 2024. The contract is a firm fixed price, delivery order type with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and will be supplying this critical medication to support various federal healthcare programs and facilities, including military treatment facilities and veterans' hospitals. The DLA is a key customer for AmerisourceBergen, and the company holds several Indefinite Delivery Contracts (IDCs) with the agency, valued up to $999,999,999, to provide a comprehensive range of pharmaceutical and medical supplies.

Generated 12/17/24, 9:21 AM